Write a reviewFor vendors
♡
Home / Investors / Ginger Liau

Ginger Liau

Venture Fund · New York City

About Ginger Liau

Venture capital investor (Partner, Bio Fund) based in New York City, New York. Focus areas include Health Care, Talent Management, Data Science. Invests at series b stage. Past investments include Alnylam Pharmaceuticals.

Investment focus

Stages
Series B
Sectors
Health CareTalent ManagementData ScienceHigh-growth StartupsE-commerceDeepTechDisruptive InnovationWellnessEnterprise SoftwareEquitiesInvestment ManagementInfrastructureAndroidCryptocurrencyAngel InvestmentStrategic PartnershipsMarketplace PlatformsEmerging MarketsBankingCloud Computing

Portfolio

No portfolio companies recorded yet; Ginger Liau reports 1 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits